Phase 3 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who weigh at least 45 kilograms (about 99 pounds).
- People whose body mass index (a measure of body weight relative to height) falls between 18.0 and just under 40.0.
- People who have been diagnosed with type 1 or type 2 diabetes, have a blood sugar control reading (HbA1c) of 9% or below, and experience pain in both legs or feet caused by diabetic nerve damage (diabetic peripheral neuropathy).
- People whose daily pain scores, recorded over a 7-day baseline period, average at least 4 and no more than 9 out of 10, with scores that stay fairly consistent across those 7 days.
Who may not be able to join:
- People who missed recording their daily pain score on more than 3 days during the 7-day baseline period.
- People who have nerve or sensory problems in their limbs that are caused by something other than diabetic peripheral neuropathy (confirm with trial site for the full list of conditions that apply).
- Other criteria defined in the study protocol may also apply, which the trial site can clarify.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 617-341-6777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change From Baseline in the Weekly Average of Daily Pain Intensity on the Numeric Pain Rating Scale (NPRS) at Week 12 Compared to Placebo
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.